Invivyd appoints Jeremy Gowler as COO/CCO, promotes Pete Schmidt to CMO

Invivyd, Inc.

Jeremy Gowler appointed COO and CCO effective Dec 16, 2022; 20 years pharma commercial experience from Sandoz/Novartis.
Pete Schmidt promoted to CMO effective immediately; previously VP clinical research; CDO Hershberger departing but consulting.
Gowler receives $440K base salary, $150K signing bonus, target annual bonus 40%, and option grant of 625,000 shares.
Option vests 25% after 1 year then monthly over 3 years; severance includes 9-12 months salary depending on circumstances.
Company advancing pipeline of monoclonal antibodies against COVID-19 and other respiratory viruses.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jeremy Gowler

Chief Operating Officer and Chief Commercial Officer

IVVD · Invivyd, Inc.

Effective: 2022-12-16
Filed: December 6, 2022, 6:59 PM ET

On December 6, 2022, Invivyd, Inc. (the “Company”) announced the appointment of Jeremy Gowler, age 46, as the Company’s Chief Operating Officer and Chief Commercial Officer, effective as of December 16, 2022 (the “Gowler Effective Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Jeremy Gowler was appointed as Chief Operating Officer and Chief Commercial Officer at Invivyd, Inc..

Action: appointed
Role: Chief Operating Officer and Chief Commercial Officer

Exact text from the filing

On December 6, 2022, Invivyd, Inc. (the “Company”) announced the appointment of Jeremy Gowler, age 46, as the Company’s Chief Operating Officer and Chief Commercial Officer, effective as of December 16, 2022 (the “Gowler Effective Date”).

View on SEC.gov

Invivyd, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-299428

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.